1. Anatomical, Physiological, and Experimental Factors Affecting the Bioavailability of sc‐Administered Large Biotherapeutics. Issue 2 (19th November 2014) Authors: Fathallah, Anas M.; Balu‐Iyer, Sathy V. Journal: Journal of pharmaceutical sciences Issue: Volume 104:Issue 2(2015:Feb.) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bridging the Gap With Clinical Pharmacology in Innovative Rare Disease Treatment Modalities: Targeting DNA to RNA to Protein. (3rd December 2022) Authors: Lee, Lucy; Gollen, Rakesh; Fathallah, Anas M.; Gao, Lan; Patil, Shivakumar Other Names: Ahmed Mariam A. guestEditor.; Bhattacharya Indranil guestEditor. Journal: Journal of clinical pharmacology Issue: Volume 62(2022)Supplement 2 Page Start: S95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of hypertonic buffer composition on lymph node uptake and bioavailability of rituximab, after subcutaneous administration. (20th December 2014) Authors: Fathallah, Anas M.; Turner, Michael R.; Mager, Donald E.; Balu‐Iyer, Sathy V. Journal: Biopharmaceutics & drug disposition Issue: Volume 36:Number 2(2015:Mar.) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunogenicity Considerations for Therapeutic Modalities Used in Rare Diseases. (3rd December 2022) Authors: Fathallah, Anas M.; Oldfield, Philip; Fiedler‐Kelly, Jill; Ramadan, Abdulraouf Other Names: Ahmed Mariam A. guestEditor.; Bhattacharya Indranil guestEditor. Journal: Journal of clinical pharmacology Issue: Volume 62(2022)Supplement 2 Page Start: S110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O‐Phospho‐l‐Serine mediates Hyporesponsiveness toward FVIII in Hemophilia A‐Murine Model by Inducing Tolerogenic Properties in Dendritic Cells. Issue 11 (29th September 2014) Authors: Fathallah, Anas M.; Ramakrishnan, Radha; Balu‐Iyer, Sathy V. Journal: Journal of pharmaceutical sciences Issue: Volume 103:Issue 11(2014:Nov.) Page Start: 3457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and pharmacokinetics of docetaxel in combination with pegvorhyaluronidase alfa in patients with non‐small cell lung cancer. Issue 5 (30th July 2021) Authors: Heineman, Thomas; Baumgart, Megan; Nanavati, Charvi; Gabrail, Nash; Van Wart, Scott A.; Mager, Donald E.; Maneval, Daniel C.; Fathallah, Anas M.; Sekulovich, Rose E. Journal: Clinical and translational science Issue: Volume 14:Issue 5(2021) Page Start: 1875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Effect of Small Oligomeric Protein Aggregates on the Immunogenicity of Intravenous and Subcutaneous Administered Antibodies. Issue 11 (30th July 2015) Authors: Fathallah, Anas M.; Chiang, Manting; Mishra, Anshul; Kumar, Sandeep; Xue, Li; Middaugh, Russell; Balu‐Iyer, Sathy V. Journal: Journal of pharmaceutical sciences Issue: Volume 104:Issue 11(2015:Nov.) Page Start: 3691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Effect of Small Oligomeric Protein Aggregates on the Immunogenicity of Intravenous and Subcutaneous Administered Antibodies. Issue 11 (November 2015) Authors: Fathallah, Anas M.; Chiang, Manting; Mishra, Anshul; Kumar, Sandeep; Xue, Li; Russell Middaugh, C.; Balu-Iyer, Sathy V. Journal: Journal of pharmaceutical sciences Issue: Volume 104:Issue 11(2015:Nov.) Page Start: 3691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗